Genomic profiling of primary and metastatic thyroid cancers

Data de publicação:

Autores da FMUP

  • Valdemar De Jesus Conde Máximo

    Autor

  • Manuel Areias Sobrinho Simões

    Autor

  • Ana Paula Soares Dias Ferreira

    Autor

Participantes de fora da FMUP

  • Melo, M
  • Zhu, YJ
  • Gazzo, A
  • Paula, AD

Unidades de investigação

Abstract

The genetic repertoire of primary thyroid cancers (TCs) is well documented, but there is a considerable lack of molecular profiling in metastatic TCs. Here, we retrieved and analyzed the molecular and clinical features of 475 primary and metastatic TCs subjected to targeted DNA sequencing, from the cBioPortal database. The cohort included primary and metastatic samples from 276 papillary thyroid carcinomas (PTCs), 5 follicular thyroid carcinomas, 22 Hurthle cell carcinomas (HCCs), 127 poorly differentiated thyroid carcinomas (PDTCs), 30 anaplastic thyroid carcinomas (ATCs) and 15 medullary thyroid carcinomas. The ATCs had the highest tumor mutational burden and the HCCs the highest fraction of the genome altered. Compared to primary PTCs, the metastases had a significantly higher frequency of genetic alterations affecting TERT (51% vs 77%, P < 0.001), CDKN2A (2% vs 10%, P < 0.01), RET (2% vs 7%, P < 0.05), CDKN2B (1% vs 6%, P < 0.05) and BCOR (0% vs 4%, P < 0.05). The distant metastases had a significantly lower frequency of BRAF (64% vs 85%, P < 0.01) and a significantly higher frequency of NRAS (13% vs 3%, P < 0.05) hotspot mutations than the lymph node metastases. Metastases from HCCs and PDTCs were found to be enriched for NF1 (29%) and TP53 (18%) biallelic alterations, respectively. The frequency of subclonal mutations in ATCs was significantly higher than in PTCs (43% vs 25%, P < 0.01) and PDTCs (43% vs 22%, P < 0.01). Metastatic TCs are enriched in clinically informative genetic alterations such as RET translocations, BRAF hotspot mutations and NF1 biallelic losses that may be explored therapeutically.

Dados da publicação

ISSN/ISSNe:
1351-0088, 1479-6821

Endocrine-Related Cancer  BioScientifica Ltd.

Tipo:
Article
Páginas:
-
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 4

Citações Recebidas na Scopus: 4

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Keywords

  • thyroid cancers; DNA sequencing; somatic mutations; copy number alterations; distant metastasis

Proyectos asociados

The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm.

Investigador Principal: Valdemar de Jesus Conde Máximo

Estudo Clínico Académico (Thyroid neoplasm) . 2023

Mitochondrial complex II genetic characterization and enzymatic expression profile in tumours of the adrenal cortex and medulla

Investigador Principal: Valdemar de Jesus Conde Máximo

Estudo Clínico Académico (Mitochondrial) . 2020

Selenium Clinical Supplementation In Autoimmune Thyroid Disease: A Portuguese Survey

Investigador Principal: Ana Paula Soares Dias Ferreira

Estudo Clínico Académico . 2022

Squamous cell carcinogenesis of the skin: Molecular characterization of prognostic therapeutic biomakers

Investigador Principal: Ana Paula Soares Dias Ferreira

Estudo Clínico Académico . 2022

Clinicopathological features and molecular biomarkers? role predicting papillary thyroid cancer patients? outcome: How to personalize and guide surgical treatment

Investigador Principal: Ana Paula Soares Dias Ferreira

Estudo Clínico Académico . 2022

Role of the MITOchondrial fission protein DRP1 as a prognosis and predictive biomarker in the treatment of differentiated thyroid cancer (ROMITO-DRP1)

Investigador Principal: Valdemar de Jesus Conde Máximo

Estudo Clínico Académico . 2022

Fatores do microambiente tumoral no cancro do ovário.

Investigador Principal: Ana Paula Soares Dias Ferreira

Estudo Clínico Académico . 2022

New Biomarkers development, validation and application in Bladder Cancer.

Investigador Principal: Valdemar de Jesus Conde Máximo

Estudo Clínico Académico . 2021

Citar a publicação

Partilhar a publicação